Sigyn Therapeutics, Inc.

Investor Relations

Latest News

View Press Release
View All News

Latest Financial Results

Q3 2020

Quarter Ended Sep 30, 2020
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Report Links

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Sigyn Therapeutics is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

View Management Team View Board of Directors

Investor Contact Information

Company

Sigyn Therapeutics, Inc.
8880 Rio San Diego Drive
Suite 800
San Diego, CA 92108
T: 619.368.2000